Device Trial Radar · NCT00597870
Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions
Last checked: Nov 20, 2026Latest source record: Sep 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
304
Actual
Start
May 2002
Primary completion
Jan 2021
Study completion Jan 2021
Sponsor
- Lead sponsor
- Rodney A. White, M.D.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 18, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this trial is to determine whether the Talent Thoracic Stent Graft, an investigational device, is a safe and effective method of treating thoracic aortic aneurysms (abnormal ballooning of the vessel wall) and other thoracic lesions (dissections, transections, pseudoaneurysms, penetrating ulcers, etc.). The endovascular method is a substitute for the major operation that is performed to treat the lesions.
Conditions
- Thoracic Aortic Aneurysms
- Thoracic Transections
- Intramural Hematoma
- Pseudoaneurysm
- Thoracic Aortic Dissection
Interventions
Endoluminal treament of thoracic lesionsDevice
Endoluminal treament of thoracic lesions with a thoracic stent-graft
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Successful Endoluminal Treatment of Thoracic LesionTime frame: Throughout study completion, an average of 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
LAC Harbor-UCLA Medical Center
Torrance, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.